You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloperoxidase Inhibitor

Showing 1 - 25 of 7,430
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple System Atrophy (MSA) Trial in Morrisville (BHV3241, verdiperstat)

No longer available
  • Multiple System Atrophy (MSA)
  • BHV3241, verdiperstat
  • Morrisville, North Carolina
    PPD
Oct 4, 2022

COPD (COPD) Trial (AZD4831, Placebo)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • (no location specified)
Aug 5, 2022

Healthy Volunteers Trial in Harrow (AZD4831, Itraconazole)

Completed
  • Healthy Volunteers
  • Harrow, United Kingdom
    Research Site
Aug 22, 2022

Healthy Volunteers Trial in Harrow (AZD4831, Midazolam)

Completed
  • Healthy Volunteers
  • Harrow, United Kingdom
    Research Site
Dec 10, 2021

Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)

Not yet recruiting
  • Coronary Artery Disease
  • +2 more
  • heated tobacco - lifestyle intervention
  • Warsaw, Poland
    National Institute of Cardiology
Dec 27, 2022

Hypertension, Aging, Sedentary Lifestyle Trial in Birmingham, Aurora, Orlando (Aerobic exercise, Perindopril, Losartan)

Recruiting
  • Hypertension
  • +2 more
  • Aerobic exercise
  • +3 more
  • Birmingham, Alabama
  • +2 more
May 6, 2022

Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)

Not yet recruiting
  • Inflammatory Response
  • Cardiac Disease
  • Colchicine 0.5 MG
  • Placebo
  • (no location specified)
Nov 1, 2023

TAAI Erasmus Research Initiative to Fight CF: Monitoring

Recruiting
  • Cystic Fibrosis
  • +9 more
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC - Sophia Children's Hospital
    Feb 21, 2023

    Inflammation, Thrombosis Trial (ticagrelor, Clopidogrel)

    Completed
    • Inflammation
    • Thrombosis
    • (no location specified)
    Aug 17, 2021

    Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)

    Terminated
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +48 more
    May 9, 2022

    Ruling Out Myelodysplastic Syndromes: Protocol forDiagnostic

    Recruiting
    • Myelodysplastic Syndromes
    • Flow cytometric analysis of neutrophil myeloperoxidase expression
    • Clermont-Ferrand, France
    • +5 more
    Mar 24, 2022

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Biochemical Analyzes to Monitor the Development of Wounds

    Completed
    • Wound
    • +5 more
      • Graz, Austria
        Division of Plastic, Aesthetic and Reconstructive Surgery, Depar
      May 17, 2021

      Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

      Not yet recruiting
      • Cervical Cancer
      • Anti-PD-1 antibody balstilimab
      • Amsterdam, Netherlands
        Amsterdam UMC
      Oct 17, 2023

      Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

      Recruiting
      • Hepatocellular Carcinoma (HCC)
      • Kaohsiung, Taiwan
      • +4 more
      Mar 14, 2023

      HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

      Not yet recruiting
      • HIV Infections
      • Las Vegas, Nevada
      • +1 more
      Aug 21, 2023

      Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

      Not yet recruiting
      • Breast Cancer
      • +4 more
      • (no location specified)
      Aug 31, 2023

      Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

      Not yet recruiting
      • Chronic Kidney Disease
      • Part A - Lorundrostat QD + Dapaglifozin QD
      • +2 more
      • (no location specified)
      Nov 27, 2023

      Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • Pavia, Lombardia, Italy
        Istituti Clinici Scientifici Maugeri
      May 5, 2023

      Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

      Not yet recruiting
      • Advanced Pancreatic Adenocarcinoma
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Aug 23, 2023

      Blood Vessel Function in Postmenopausal Women With Breast Cancer

      Active, not recruiting
      • Breast Cancer
      • Rochester, Minnesota
        Mayo Clinic
      Jan 17, 2023

      Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

      Not yet recruiting
      • Adenoid Cystic Carcinoma
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Mar 14, 2023

      Healthy Trial in Biberach (BI 1810631, Itraconazole)

      Recruiting
      • Healthy
      • Biberach, Germany
        Humanpharmakologisches Zentrum Biberach
      Apr 27, 2023

      Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Birmingham, Alabama
      • +2 more
      Jan 3, 2023